← Evidence map

ArticleStroke2024

Baseline Stroke Risk and Efficacy of Dual-Antiplatelet Therapy: A Post Hoc Analysis of the POINT Trial.

Iyas Daghlas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2024
2025
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 38174567